Unexpected HBsAg decrease after nucleoside analogues retreatment among HBeAg positive postpartum women: a pilot study

Unexpected HBsAg decrease after nucleoside analogues retreatment among HBeAg positive postpartum women: a pilot study

Abstract Background Mother-to-child transmission (MTCT) is one of the main routes of transmission of HBV, and previous studies focused on the efficacy and safety of nucleoside analogues (NAs) in preventing MTCT. There are limited data on virologic changes of chronic hepatitis B (CHB) patients after...

Podrobná bibliografie
Hlavní autoři:	Qiao Tang, Chunrui Wang, Hu Li, Zhiwei Chen, Li Zhang, Jing Zhang, Xiaoqing Liu, Yunling Xue, Yue Qiu, Mingli Peng, Yi Zeng, Peng Hu
Médium:	Článek
Jazyk:	English
Vydáno:	BMC 2025-02-01
Edice:	Virology Journal
Témata:	Mother-to-child transmission ALT abnormal Liver fibrosis Virologic response Treatment discontinuation
On-line přístup:	https://doi.org/10.1186/s12985-025-02632-x

Podobné jednotky

HBsAg protein composition and clinical outcomes in chronic hepatitis D and variations across HBeAg-negative chronic HBsAg carriers
Autor: Luisa Roade, a další
Vydáno: (2023-10-01)

Circulating immune complexes and mutations of HBsAg are associated with the undetectable HBsAg in anti-HBs and HBeAg positive occult hepatitis B virus infection
Autor: Ying Yan, a další
Vydáno: (2022-11-01)

Serum HBsAg and HBcrAg is associated with inflammation in HBeAg-positive chronic hepatitis B patients
Autor: Jing Zhao, a další
Vydáno: (2023-03-01)

Deteksi HBsAg dan HBeAg dalam Saliva Pengidap Virus Hepatitis B
Autor: Riemawati A. Lesmana
Vydáno: (2015-10-01)

Longitudinal change of HBsAg in HBeAg-negative patients with genotype B or C infection.
Autor: Tung-Hung Su, a další
Vydáno: (2013-01-01)

Incidence and predictors of HBV relapse after cessation of nucleoside analogues in HBeAg-negative patients with HBsAg ≤ 200 IU/mL
Autor: Chih-Chien Yao, a další
Vydáno: (2017-05-01)

Changes in viral load and HBsAg and HBeAg status with age in HBV chronic carriers in The Gambia
Autor: Crozier Sarah, a další
Vydáno: (2008-04-01)

Quantitative HBsAg: Not helpful to evaluate fibrosis in HBeAg-negative chronic hepatitis B patients
Autor: Dimitri Loureiro, a další
Vydáno: (2019-01-01)

Correlation between HBsAg quantitation and HBV DNA in HBeAg-Negative HBV/D patients
Autor: Anouar Teriaky, a další
Vydáno: (2013-01-01)

Triple motif proteins 19 and 38 correlated with treatment responses and HBsAg clearance in HBeAg-negative chronic hepatitis B patients during peg-IFN-α therapy
Autor: Haiying Luo, a další
Vydáno: (2023-07-01)

Changes in the Prevalence of HBsAg and HBeAg: a Study of 8696 Parturients in a Well Vaccinated Area
Autor: Chen-Hsuan Wu, a další
Vydáno: (2017-04-01)

Coexistence of HBsAg/Anti-HBs and HBeAg/Anti-HBe in Sudanese Patients with Chronic Hepatitis B Virus Infection: A Cross-Sectional Study
Autor: Taqwa Hashim, a další
Vydáno: (2023-12-01)

End-of-treatment anti-HBs levels and HBeAg status identify durability of HBsAg loss after PEG-IFN discontinuation
Autor: Yifei Guo, a další
Vydáno: (2023-02-01)

Quantification of HBsAg to predict low levels and seroclearance in HBeAg-negative patients receiving nucleos(t)ide analogues.
Autor: Teresa Broquetas, a další
Vydáno: (2017-01-01)

Quantitative HBsAg levels do not identify hepatic fibrosis in HBeAg-negative chronic hepatitis B patients
Autor: Fatima A Ahmed, a další
Vydáno: (2019-01-01)

Quantitative HBsAg and Qualitative HBeAg Predicts Intrauterine Placental Infection and Umbilical Blood Cord in Pregnant Women
Autor: Erry Gumilar Dachlan, a další
Vydáno: (2020-10-01)

HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients
Autor: Cheng-Yuan Peng, a další
Vydáno: (2015-04-01)

CTLA-4 haplotype predicts HBsAg and HBcrAg levels and HBeAg seroconversion age in children with chronic HBV infection
Autor: Jia-Feng Wu, a další
Vydáno: (2024-05-01)

The presence of baseline HBsAb-Specific B cells can predict HBsAg or HBeAg seroconversion of chronic hepatitis B on treatment
Autor: Shengxia Yin, a další
Vydáno: (2023-12-01)

HBsAg isoform dynamics during NAP‐based therapy of HBeAg‐negative chronic HBV and HBV/HDV infection
Autor: Michel Bazinet, a další
Vydáno: (2022-08-01)

Caucasian Ethnicity, but Not Treatment Cessation Is Associated with HBsAg Loss Following Nucleos(t)ide Analogue-Induced HBeAg Seroconversion
Autor: Stijn Van Hees, a další
Vydáno: (2019-07-01)

Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo, hinder HBsAg secretion in vitro and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infection
Autor: Romina Salpini, a další
Vydáno: (2020-01-01)

Study on pathological and clinical characteristics of chronic HBV infected patients with HBsAg positive, HBV DNA negative, HBeAg negative
Autor: Zhan Zeng, a další
Vydáno: (2023-01-01)

Predictors of HBsAg seroclearance in HBeAg-negative chronic hepatitis B patients treated with nucleotide analogs plus polyethylene glycol interferon
Autor: Yan Peng, a další
Vydáno: (2025-01-01)

Mitogen-activated protein kinase eight polymorphisms are associated with immune responsiveness to HBV vaccinations in infants of HBsAg(+)/HBeAg(−) mothers
Autor: Meng Zhuo Cao, a další
Vydáno: (2018-06-01)

Alteration of the Immune Microenvironment in HBsAg and HBeAg Dual-Positive Pregnant Women Presenting a High HBV Viral Load
Autor: Gao F, a další
Vydáno: (2021-10-01)

Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levels.
Autor: Elisabetta Loggi, a další
Vydáno: (2013-01-01)

Increased Coffee Intake Reduces Circulating HBV DNA and HBsAg Levels in HBeAg-Negative Infection: A Cohort Study
Autor: Jack Bee Chook, a další
Vydáno: (2019-09-01)

Possible immunochemical pattern of anti-HCV, HBeAg, HBsAg HBeAb, and HIV-1 p24 in newly infected Mycobacterium pulmonary tuberculosis patients
Autor: Mathew Folaranmi Olaniyan, a další
Vydáno: (2019-01-01)

Increasing on-treatment hepatocellular carcinoma risk with decreasing baseline viral load in HBeAg-positive chronic hepatitis B
Autor: Won-Mook Choi, a další
Vydáno: (2022-05-01)

Correlation of fulminant hepatitis B, HBeAg start-codon depletions and escape mutations in the 2nd loop of the HBsAg a-determinant
Autor: T. Michler, a další
Vydáno: (2014-04-01)

Prevalence of HBe Ag and LFT Survey in HBsAg Positive Blood Donors in Kerman
Autor: M.J Zahedi, a další
Vydáno: (2003-07-01)

HBsAg clearance and seroconversion case in a patient with HBeAg-negative chronic hepatitis B on pegylated interferon α-2a therapy
Autor: K. V. Zhdanov, a další
Vydáno: (2014-09-01)

Study of hepatic histomorphology in HBeAg+ and HBeAg− patients with CHB: Experience from Bangladesh
Autor: Ayub Al Mamun, a další
Vydáno: (2013-01-01)

Significant liver histological change is common in HBeAg-positive chronic hepatitis B with normal ALT
Autor: Menghui Duan, a další
Vydáno: (2024-07-01)

Persistence and immune memory to hepatitis B vaccine 20 years after primary vaccination of Thai infants, born to HBsAg and HBeAg positive mothers
Autor: Yong Poovorawan, a další
Vydáno: (2012-07-01)

Clinical outcomes of treatment-naïve HBeAg-negative patients with chronic hepatitis B virus infection with low serum HBsAg and undetectable HBV DNA
Autor: Jian Wang, a další
Vydáno: (2024-12-01)

Factors Predicting HBsAg Seroclearance and Alanine Transaminase Elevation in HBeAg-Negative Hepatitis B Virus-Infected Patients with Persistently Normal Liver Function.
Autor: Tai-Long Chien, a další
Vydáno: (2016-01-01)

Correlations of HBV Genotypes, Mutations Affecting HBeAg Expression and HBeAg/ anti-HBe Status in HBV Carriers
Vydáno: (2006-01-01)

PgRNA closely correlates to cytokine profile in HBeAg-positive pregnant women undergoing prophylactic antiviral intervention
Autor: Qiao Tang, a další
Vydáno: (2024-12-01)